Administration Time-dependent Antihypertensive Effects of Low Dose Aspirin in Well-controlled Hypertensive Patients
NCT00386529 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 191
Last updated 2010-12-15
Summary
The purpose of this study is to evaluate the influence of aspirin on blood pressure in well-controlled hypertensive patients who receive low dose aspirin at different times of the day
Conditions
- Well-controlled Hypertension
Interventions
- DRUG
-
Aspirin enteric coated pellests 100mg
Sponsors & Collaborators
-
Kyungpook National University Hospital
collaborator OTHER -
The Catholic University of Korea
collaborator OTHER -
Cheil General Hospital and Women's Healthcare Center
collaborator OTHER -
Inje University
collaborator OTHER -
Keimyung University
collaborator OTHER -
Seoul National University Bundang Hospital
collaborator OTHER -
Severance Hospital
collaborator OTHER -
Yeungnam University Hospital
collaborator OTHER -
Boryung Pharmaceutical Co., Ltd
lead INDUSTRY
Principal Investigators
-
Shung Chull Chae, Professor · Kyungpook National University Hospital
-
Dong Ju Choi, Professor · Seoul National University Bundang Hospital
-
Dong Su Kim, Professor · Inje University
-
Jeong Bae Park, Professor · Cheil General Hospital and Women's Healthcare Center
-
Nam Sik Chung, Professor · Severance Hospital
-
Sang Hong Baek, Professor · The Catholic University of Korea
-
Chang Wook Nam, Professor · Keimyung University Dongsan Medical Center
-
Young Jo Kim, Professor · Yeungnam University Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 30 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-09-30
- Primary Completion
- 2007-01-31
- Completion
- 2008-08-31
Countries
- South Korea
Study Locations
More Related Trials
-
A Study to Investigate the Influence of MK0859 on Blood Pressure (MK-0859-012)(COMPLETED)
NCT00565006 ·Status: COMPLETED ·Phase: PHASE1
-
Antihypertensive Efficacy and Tolerability and Determine the Adequate Antihypertensive Dosage of Fimasartan in Mild to Moderate Essential Hypertension Patients
NCT00923611 ·Status: COMPLETED ·Phase: PHASE2
-
A Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan (BR-A-657•K) During 24 Hours in Patients With Mild to Moderate Essential Hypertension
NCT00922441 ·Status: COMPLETED ·Phase: PHASE2
-
Fimasartan (BR-A-657) Single Oral Dose in Healthy Subjects
NCT01289886 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Hypertension Patients
NCT00922480 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial to Evaluate the Effect of Fimarsartan on Pharmacodynamics, Pharmacokinetics, and the Safety of Warfarin in Healthy Male Volunteers
NCT00938132 ·Status: COMPLETED ·Phase: PHASE1
-
A Valsartan 80 Mg-Referenced, Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan 30 mg During 24 Hours in Patients With Mild to Moderate Essential Hypertension
NCT01878201 ·Status: COMPLETED ·Phase: PHASE2
-
Study Describing the Hypertensive Population Treated With Telmisartan and Conditions of Use by Medical Practitioners and Patients
NCT02242851 ·Status: COMPLETED
-
Efficacy and Safety of Valsartan and the Combination of Valsartan and Simvastatin
NCT00385931 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Blood Pressure Reduction on High Sensitivity C-Reactive Protein (hsCRP)
NCT00154271 ·Status: COMPLETED ·Phase: PHASE4
-
Telmisartan in Mild to Moderate Hypertensive Patients
NCT02260089 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil Alone
NCT01456169 ·Status: COMPLETED ·Phase: PHASE3
-
Challenge Test for Acetylsalicylic Acid Hypersensitivity
NCT01681615 ·Status: UNKNOWN ·Phase: NA
-
Pharmacovigilance and Patient Compliance in Hypertensive Patients
NCT02200575 ·Status: COMPLETED
-
Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential Hypertension
NCT01289132 ·Status: COMPLETED ·Phase: PHASE2
-
Antihypertensive Efficacy and Safety of Candesartan/HCT 32/12.5 and 32/25 mg in Comparison With Candesartan 32 mg
NCT00383929 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Investigate the Influence of CKD-519 on 24-h Ambulatory Blood Pressure in Healthy Adult Volunteers
NCT02916901 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of fimaSartan on arTerIal stiFFness iN patiEntS With HypertenSion
NCT02022774 ·Status: COMPLETED
-
Efficacy, Safety and Pharmacodynamic/Pharmacokinetic Study of Fimasartan (BR-A-657•K)
NCT00937651 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Comparing Telmisartan vs Valsartan. Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension
NCT00168779 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Aliskiren 300 mg Compared to Telmisartan 80 mg After 1 Week of Treatment Withdrawal
NCT00865020 ·Status: COMPLETED ·Phase: PHASE4
-
Azilsartan Tablets Special Drug Use Surveillance: Long-term Use
NCT02092025 ·Status: COMPLETED
-
Effect of High- and Low-sodium Intake on the Pharmacokinetics and Pharmacodynamic Effects of Fimasartan
NCT02147704 ·Status: COMPLETED ·Phase: PHASE4
-
The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension
NCT01135212 ·Status: COMPLETED ·Phase: PHASE3
-
Phase III Clinical Study to Evaluate the Efficacy and Safety of the Combination of Lercanidipine/Valsartan in Hypertensive Patients
NCT01928628 ·Status: COMPLETED ·Phase: PHASE3